当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析 - 现金流量表

贝达药业

(300558)

  

流通市值:232.76亿  总市值:233.51亿
流通股本:4.19亿   总股本:4.21亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,731,866,820.84904,214,287.023,162,820,863.132,472,704,308.44
  收到的税费返还606,964.671,119.7710,000-
  收到其他与经营活动有关的现金86,505,923.7864,545,475.4756,961,727.8775,478,085.66
  经营活动现金流入小计1,818,979,709.29968,760,882.263,219,792,5912,548,182,394.1
  购买商品、接受劳务支付的现金237,570,385.1381,951,546.95414,772,859.69207,021,761.38
  支付给职工以及为职工支付的现金329,068,745.66208,785,163.25602,676,778.61476,325,113.84
  支付的各项税费147,204,205.6161,887,566.01116,659,370.9997,480,877.11
  支付其他与经营活动有关的现金660,158,084.68318,600,918.041,174,511,405.49936,013,902.98
  经营活动现金流出小计1,374,001,421.08671,225,194.252,308,620,414.781,716,841,655.31
  经营活动产生的现金流量净额444,978,288.21297,535,688.01911,172,176.22831,340,738.79
二、投资活动产生的现金流量:
  收回投资收到的现金--31,581,183.161,910,448.97
  处置固定资产、无形资产和其他长期资产收回的现金净额14,509.42100,000141,527140,367
  投资活动现金流入小计14,509.42100,00031,722,710.162,050,815.97
  购建固定资产、无形资产和其他长期资产支付的现金391,306,234.66192,857,786.75827,594,838.86608,048,344.6
  投资支付的现金--205,820,833.79175,684,977.02
  投资活动现金流出小计391,306,234.66192,857,786.751,033,415,672.65783,733,321.62
  投资活动产生的现金流量净额-391,291,725.24-192,757,786.75-1,001,692,962.49-781,682,505.65
三、筹资活动产生的现金流量:
  吸收投资收到的现金92,166,278---
  取得借款收到的现金580,000,000150,000,000533,600,000483,600,000
  收到其他与筹资活动有关的现金--111,150,000-
  筹资活动现金流入小计672,166,278150,000,000644,750,000483,600,000
  偿还债务支付的现金532,810,000150,010,000659,120,000581,120,000
  分配股利、利润或偿付利息支付的现金118,423,284.5619,326,846.43150,872,677.7102,774,076.8
  支付其他与筹资活动有关的现金18,916,728.678,854,00026,141,106.2-
  筹资活动现金流出小计670,150,013.23178,190,846.43836,133,783.9683,894,076.8
  筹资活动产生的现金流量净额2,016,264.77-28,190,846.43-191,383,783.9-200,294,076.8
四、汇率变动对现金及现金等价物的影响-196,210.48-133,207.851,590,510.79-6,019,687.56
五、现金及现金等价物净增加额55,506,617.2676,453,846.98-280,314,059.38-156,655,531.22
  加:期初现金及现金等价物余额471,682,855.12471,682,855.12751,996,914.5751,996,914.5
  期末现金及现金等价物余额527,189,472.38548,136,702.1471,682,855.12595,341,383.28
补充资料:
  净利润130,707,401.1-386,979,402.58-
  资产减值准备-2,647,368.81-21,156,712.37-
  固定资产和投资性房地产折旧93,425,612.98-115,204,009.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧93,425,612.98-115,204,009.77-
  无形资产摊销176,142,112.02-252,937,958.86-
  处置固定资产、无形资产和其他长期资产的损失-72,940.02-588,954.91-
  固定资产报废损失3,848.86-591,577.32-
  公允价值变动损失76,016,377.9-26,305,321.32-
  财务费用40,840,938.22-44,044,061.2-
  投资损失6,504,780.23-14,663,608.75-
  递延所得税-8,304,545.62-3,169,078.15-
  其中:递延所得税资产减少-3,627,974.82-28,986,293.78-
    递延所得税负债增加-4,676,570.8--25,817,215.63-
  存货的减少-35,869,860.82-37,416,647.1-
  经营性应收项目的减少-83,045,735.68-156,534,353.23-
  经营性应付项目的增加29,486,790.15--95,111,432.99-
  其他20,254,484.88--57,132,509.58-
  现金的期末余额527,189,472.38-471,682,855.12-
  减:现金的期初余额471,682,855.12-751,996,914.5-
  现金及现金等价物的净增加额55,506,617.26--280,314,059.38-
公告日期2025-08-202025-04-252025-04-182024-10-29
审计意见(境内)标准无保留意见
TOP↑